Fig. 1From: Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort studyThe virological responses at different time-points for CHC patients receiving SOF-based regimensBack to article page